AURAGEN

AURAGEN is one of of the two national high throughput sequencing platforms selected within the framework of the Plan France médecine génomique 2025 (the French initiative for genomic medicine – led by AVIESAN) set up to ensure that everyone has access to new technologies in genomic medicine in an equitable manner throughout the country. AURAGEN provides access to high throughput sequencing to all actors involved in cancerology and management of rare diseases in the Auvergne Rhône-Alpes region.

  1. Showing 1 result for:
  2. AURAGEN
All Regions

Sequencing and Bioinformatics

Provided by AURAGEN

Auragen

Auragen offers access to very high throughput sequencing to players involved in oncology and in the management of rare diseases. DNA / RNA extraction and sequencing are carried out in the medical biology laboratory located in the premises of the HCL (Hospices Civils de Lyon). The bioinformatics processing of the sequences is carried out on the sites of the CHUGA (CHU Grenoble-Alpes) and the CLB ( Center Léon Bérard ). The data are analyzed and interpreted in the various partner establishments of the GCS by AURAGEN experts and colleagues competent in the patient’s pathology.

Visit website